BioXcel Therapeutics, Inc. (BTAI)
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Investigation
12/09/2020
Resolution
10/08/2021
Investigation regarding FireEye’s disclosures about a cyber-attack, the date of the attack and whether FireEye failed to disclose to shareholders the event and its magnitude on time.
12/08/2020
After the market close, FireEye disclosed a cyber-attack, along with shared details about the actions it took to respond to it. FireEye disclosed that the hackers stole its Red Team Tools: “The stolen tools range from simple scripts used for automating reconnaissance to entire frameworks that are similar to publicly available technologies such as CobaltStrike and Metasploit. Many of the Red Team tools have already been released to the community and are already distributed in our open-source virtual machine, CommandoVM.“
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$13.49 | $15.52 | $-2.03 | -13.08% |
We have marked this investigation as closed.
The company completed a divestiture of the business.
On 10/08/2021 the company issued the following statement:
Mandiant completed the divestiture of its FireEye Products Business to McAfee Enterprise. On October 8, 2021, the company announced “the completion of the previously announced transaction to sell the FireEye Products business to McAfee Enterprise, which is backed by a consortium led by Symphony Technology Group (STG), in an all-cash transaction for $1.2 billion, before taxes and transaction-related expenses. Mandiant and the combined McAfee Enterprise and FireEye Products company will continue to support customers post-closing with a joint reseller relationship, shared product telemetry and frontline threat intelligence.“
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.